Diligent Pharma
Philadelphia
About Diligent Pharma
Diligent Pharma is a platform that streamlines the selection and qualification of clinical trial service providers. It simplifies and accelerates the process for identification, selection, and qualification of clinical trial service providers. Trial sponsors can access standardized Vendor Qualification Assessment (VQA) reports and Request for Information (RFI) information from Diligent. As a result, they will require significantly less time and money to qualify a GCP vendor before beginning a clinical investigation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.3M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2023)
- Website: diligentpharma.com
- Phone: 6096102815
Industries & Categories
Computer, Industrial Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/diligent-pharma-33456 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.